Updates are available Correction dated 2024-06-10
Click to view Correction: https://doi.org/10.1038/s41591-024-03107-2
-
Authors
Zhong, Youjia http://orcid.org/0000-0002-3795-6319
Kang, Alicia Y. H.
Tay, Carina J. X.
Li, Hui’ En
Elyana, Nurul
Tan, Chee Wah http://orcid.org/0000-0001-9837-1413
Yap, Wee Chee
Lim, Joey M. E. http://orcid.org/0000-0003-4775-2376
Le Bert, Nina http://orcid.org/0000-0003-0502-2527
Chan, Kuan Rong http://orcid.org/0000-0002-2427-671X
Ong, Eugenia Z.
Low, Jenny G.
Shek, Lynette P. http://orcid.org/0000-0001-9064-8983
Tham, Elizabeth Huiwen http://orcid.org/0000-0003-1037-6143
Ooi, Eng Eong http://orcid.org/0000-0002-0520-1544
-
Funding
Funding for this research was provided by:
MOH | National Medical Research Council (NUHSRO/2021/081/NUS Med/07/MARVELS)
- License Information
-
More Information
Article History
Received: 22 September 2023
Accepted: 29 March 2024
First Online: 30 April 2024
Change Date: 10 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-024-03107-2
Competing interests
: N.L.B. reports a patent for a method to monitor SARS-CoV-2-specific T cells in biological samples, which is pending. The other authors declare no competing interests.
